Merit Medical Systems | MMSI - Loan Capital


Merit Medical Systems reported $735.16M in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
3M USD 10.91B 26M Mar/2026
Abbott USD 29.64B 19.74B Mar/2026
AngioDynamics USD 5.6M 100K Sep/2025
AtriCure USD 61M 865K Mar/2026
Baxter International USD 8.62B 852M Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Cooper Companies USD 1.86B 17.7M Mar/2026
Dexcom USD 1.3B 54.4M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Haemonetics USD 1.22B 299.58M Mar/2026
ICU Medical USD 1.26B 4.09M Mar/2026
Insulet USD 929.5M 1.3M Mar/2026
Integra LifeSciences USD 1.83B 29.45M Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Merit Medical Systems USD 735.16M 1.12M Mar/2026
Olympus JPY 159.7B 61M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
STAAR Surgical USD 42K 42K Dec/2023
Stryker USD 14.22B 635M Mar/2026
Surmodics USD 29.67M 116K Jun/2025
Tandem Diabetes Care USD 601.77M 291.73M Mar/2026
Teleflex USD 2.51B 27.18M Mar/2026
Terumo JPY 99.91B 13M Mar/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026